Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Haematology|April 8, 2015
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative diseaseJosé Luis Piñana, Jaime Sanz, Albert Esquirol, et al.
Bone Marrow Transplantation|December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remissionJaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Experimental Hematology|March 13, 2018
Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusionsGuillermo Ortí, Jaime Sanz, Irene García-Cadenas, et al.
Bone Marrow Transplantation|July 14, 2022
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, et al.
Bone Marrow Transplantation|February 9, 2019
Author Correction: Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantationGuillermo Ortí, Irene García-Cadenas, Lucia López-Corral, et al.
Bone Marrow Transplantation|May 23, 2021
Legionellosis after hematopoietic stem cell transplantationMalgorzata Mikulska, Gloria Tridello, Jennifer Hoek, et al.
Transplantation|October 8, 2005
Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodiesJacques-Olivier Bay, Nathalie Dhédin, Martin Goerner, et al.
European Journal of Haematology|February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMTLaurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
Bone Marrow Transplantation|June 15, 2021
Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?Jesus Fernandez-Sojo, Carmen Azqueta, Elena Valdivia, et al.
Bone Marrow Transplantation|April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
Pageof 3